Trial · NCT06556719
Hoosier Sport Re-Social: A Biobehavioral Intervention in Rural Indiana
NCT06556719, Not applicable, Completed, Indiana University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Hoosier Sport Re-Social: A Biobehavioral Intervention in Rural Indiana. Trials, record NCT06556719. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06556719
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Hoosier Sport Re-Social: A Biobehavioral Intervention in Rural Indiana
- NCT number
- NCT06556719
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 32 participants, actual
- Lead sponsor
- Indiana University
- Conditions
- CVD, Sedentary Behavior
- Interventions
- Hoosier Sport Re-Social
- First posted
- 2024-08-16
- Last updated
- 2025-05-06
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility of Intervention Measure (FIM) | Measured at week 0 and week 6 | How feasible the intervention was from the perspective of the participants. This is measured through questionnaire. |
| Primary | Acceptability of Intervention Measure (IAM) | Measured at week 0 and week 6 | How acceptable the intervention is to the participants. This is measured through questionnaire. |
| Primary | Intervention Appropriateness Measure (AIM) | Measured at week 0 and week 6 | How appropriate the intervention is to the participants. This is measured through questionnaire. |
| Secondary | Daily Total Physical Activity of Participants | Week 1 (for 7 days), and week 6 (for 7 days) | Accelerometers (Axivity - AX3 model) will be used to track total daily physical activity |
| Secondary | Heart Rate of Participants | HR will be taken at week 0 and week 6 before and following the 6-minute walk test. | heart rate measured via a blood pressure monitor |
| Secondary | Blood Pressure of Participants | BP will be taken at week 0 and week 6 before and following the 6-minute walk test. | Blood pressure measured via a blood pressure monitor |
| Secondary | Basic Psychological Needs of Participants in Intervention Environment | Assessed at week 0 and week 6 | Basic Psychological Needs and Satisfaction and Frustration scale. This entails feelings/perceptions of autonomy, relatedness, competence, enjoyment, satisfaction, and frustration in the study setting. Higher scores indicate greater satisfaction. |
| Secondary | Physical Literacy of Participants | Assessed at week 0 and week 6 | the Canadian Assessment of Physical Literacy second addition (CAPL-2) will be used. A higher score on the CAPL-2 indicates higher physical literacy. |
| Secondary | Cardiovascular Fitness Levels of Participants | Assessed at week 0 and week 6 | the 6-minute walk test will be used to assess changes in fitness. Greater distance walked in the 6 minute time frame is related to greater levels of cardiovascular fitness. |
| Secondary | Muscular Endurance Levels of Participants | Assessed at week 0 and week 6 | The plank test will be used to assess changes in fitness. The longer the plank is held, the greater the muscular endurance of the participant. |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 40855334 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Stroop Color-Word Test | Secondary outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06556719
GET https://conductscience.org/api/trials/v1/NCT06556719/registered